Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06359106
Other study ID # 2024.3.1
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date May 10, 2024
Est. completion date December 31, 2025

Study information

Verified date April 2024
Source China Medical University, China
Contact Tianhao Zhang, M.D.
Phone +862483283100
Email zhth774176947@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This was a multicenter, prospective, parallel-grouping, randomized controlled clinical study comparing low FiO2 (40%) and high FiO2 (80%) levels in older patients undergoing laparoscopic gastrointestinal surgery.


Description:

This was a multicenter, prospective, parallel-grouping, randomized controlled clinical study comparing low FiO2 (40%) and high FiO2 (80%) levels in older patients undergoing laparoscopic gastrointestinal surgery. the investigators planned to enroll 1098 subjects aged > 65 years for laparoscopic gastrointestinal surgery at 19 clinical trial centers in China, randomized in a 1:1 ratio, to use two inhaled oxygen concentrations during surgery. All patients will be performed via the lung-protective ventilation strategy. The respiratory parameters are VT: 6-8ml/kg, PEEP: 6-8 cmh2O, RR: 1:2, and respiratory rate will be adjusted by maintaining a partial pressure of carbon dioxide at 35-45 mmHg. Manual lung recruitment maneuvers will be performed after tracheal intubation and before tracheal extubation. The main outcome measure was the oxygenation index on the postoperative 48h. The secondary outcome measures were the 7-day postoperative pulmonary complications and 30-day mortality rates et al.


Recruitment information / eligibility

Status Recruiting
Enrollment 1098
Est. completion date December 31, 2025
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Age not less than 65 years - American Society of Anesthesiologists grades I-III - No history of drug allergies or abnormal anesthesia. - The duration of mechanical ventilation was expected to be more than 2 hours. - Laparoscopic Gastrointestinal Surgery - The preoperative oxygen saturation was not less than 94%. - The patients will be planned to extubate in the operating room. Exclusion Criteria: - History of acute lung injury or acute respiratory distress syndrome (ARDS) within 3 months. - Cardiac function Class IV (New York Heart Association classification) - Chronic renal failure (renal cell filtration rate <30 ml min-11.73/m2), severe liver disease - Patients with blurred consciousness and cognitive dysfunction - Severe coagulation dysfunction. - Without preoperative oxygen inhalation, blood oxygen level <94%, and severe pulmonary dysfunction - Patients with endotracheal tubes were admitted to the intensive care unit (ICU) after surgery. - Body mass index (BMI) >30kg/m2 - Inability to complete the study

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
80% Oxygen
After successful anesthesia induction, the fraction of inspired oxygen (FiO2) will be adjusted to 80%, and the total gas flow rate will be set at 2L/minute.
40% Oxygen
After successful anesthesia induction, the fraction of inspired oxygen (FiO2) will be adjusted to 40%, and the total gas flow rate will be set at 2L/minute.

Locations

Country Name City State
China Beijing Friendship Hospital, Capital Medical University Beijing
China Sichuan Provincial People's Hospital Chendu
China Chifeng Municipal Hospital Chifeng
China First Affiliated Hospital of Chongqing Medical University Chongqi
China Dalian Third People's Hospital Dalian
China First Affiliated Hospital, Dalian Medical University Dalian
China First Affiliated Hospital of Harbin Medical University Harbin
China Harbin Medical University Cancer Hospital Harbin
China First Hospital, Jilin University Jilin
China Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan
China First Medical University and Shandong Provincial Qianfoshan Hospital Jinan
China First Affiliated Hospital of Kunming Medical University Kunming
China Affiliated Hospital of Qingdao University Qingdao
China Fourth Affiliated Hospital of China Medical University Shenyang Liaoning
China Liaoning Cancer Hospital and Institute Shenyang
China the First Hospital of China Medical University Shenyang Liaoning
China Shenzhen People's Hospita Shenzhen
China First Hospital of Hebei Medical University Shijia Zhuang
China Second Hospital of Hebei Medical University Shijia Zhuang
China Tianjin Fifth Central Hospital Tianjin
China YANBIAN University Hospital(Yanbian Hospital) Yanbian

Sponsors (1)

Lead Sponsor Collaborator
China Medical University, China

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oxygenation Index The primary outcome was the comparison of the oxygenation index between the two groups. Oxygenation index of acute lung injury is 200, and higher scores mean worse outcome. On the postoperative 48th hour
Secondary pH value in blood gas analysis 48 hours after the operation pH of blood gas analysis 48 hours after the operation On the postoperative 48th hour
Secondary oxygen inhalation time oxygen inhalation time On the postoperative 48 hour
Secondary inspired oxygen concentration inspired oxygen concentration On the postoperative 48 hour
Secondary oxygen uptake rate oxygen uptake rate On the postoperative 48 hour
Secondary 7 days pulmonary complications 7 days pulmonary complications On the postoperative 7th day
Secondary 30-day Mortality 30-day Mortality On the postoperative 30th day
Secondary PaCO2 in blood gas analysis 48 hours after the operation PaCO2 of blood gas analysis 48 hours after the operation On the postoperative 48th hour
Secondary Lactic acid in blood gas analysis 48 hours after the operation Lactic acid in blood gas analysis 48 hours after the operation On the postoperative 48th hour
See also
  Status Clinical Trial Phase
Recruiting NCT02026739 - The Optimal Intraoperative Supplemental Oxygen Administration During Minimally Invasive Esophagectomy N/A